Voclosporin FDA approval date

The FDA approved Voclosporin on 22 Jan 2021.

FDA approval date
22 Jan 2021

Drug identity checked against registry records

Included trials

TrialSponsorPhaseStatusPrimary completion
Voclosporin in Adolescent and Pediatric Subjects With Lupus NephritisNCT05288855AUPHPhase 3Terminated2025-07-03Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2021-01-22DayVoclosporinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA213716", "applicant_as_listed_by_fda": "AURINIA", "brand_names": ["LUPKYNIS"], "active_ingredients": ["VOCLOSPORIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20210122", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026